Richard Ambinder - Publications

Johns Hopkins University, Baltimore, MD 
Molecular Biology, Cell Biology, Microbiology Biology

249 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lee J, Kosowicz JG, Hayward SD, Desai P, Stone J, Lee JM, Liu JO, Ambinder RF. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression Without Virion Production. Journal of Virology. PMID 31341058 DOI: 10.1128/JVI.00998-19  0.4
2019 Keller MD, Darko S, Lang H, Ransier A, Lazarski CA, Wang Y, Hanley PJ, Davila BJ, Heimall JR, Ambinder RF, Barrett AJ, Rooney CM, Heslop HE, Douek DC, Bollard CM. T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy. British Journal of Haematology. PMID 31219185 DOI: 10.1111/bjh.16053  0.4
2019 Messmer M, Tsai HL, Varadhan R, Swinnen LJ, Jones RJ, Ambinder RF, Shanbhag SP, Borowitz MJ, Wagner-Johnston N. R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma. Leukemia & Lymphoma. 1-5. PMID 30656983 DOI: 10.1080/10428194.2018.1519812  0.32
2018 Elmariah H, Kasamon YL, Zahurak M, Macfarlane KW, Tucker N, Rosner GL, Bolaños-Meade J, Fuchs EJ, Wagner-Johnston N, Swinnen LJ, Huff CA, Matsui WH, Gladstone DE, McCurdy SR, Borrello I, ... ... Ambinder RF, et al. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29452245 DOI: 10.1016/j.bbmt.2018.02.005  0.32
2018 Shenderov E, Ambinder RF. Resistance Is Futile: Engineering the Adoptive T-Cell Therapies of the Future. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017766618. PMID 29364774 DOI: 10.1200/JCO.2017.76.6618  0.48
2018 Kasamon YL, Fuchs EJ, Zahurak M, Rosner GL, Symons HJ, Gladstone DE, Huff CA, Swinnen LJ, Brodsky RA, Matsui WH, Borrello I, Shanbhag S, Cooke KR, Ambinder RF, Luznik L, et al. Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical BMT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29353109 DOI: 10.1016/j.bbmt.2018.01.011  0.32
2017 Duffield AS, Ascierto ML, Anders RA, Taube JM, Meeker AK, Chen S, McMiller TL, Phillips NA, Xu H, Ogurtsova A, Berger AE, Pardoll DM, Topalian SL, Ambinder RF. Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy. Blood Advances. 1: 1324-1334. PMID 29296775 DOI: 10.1182/bloodadvances.2017007260  0.32
2017 Kasamon YL, Ambinder RF, Fuchs EJ, Zahurak M, Rosner GL, Bolaños-Meade J, Levis MJ, Gladstone DE, Huff CA, Swinnen LJ, Matsui WH, Borrello I, Brodsky RA, Jones RJ, Luznik L. Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide. Blood Advances. 1: 288-292. PMID 29242852 DOI: 10.1182/bloodadvances.2016002766  0.32
2017 McCurdy SR, Kanakry CG, Tsai HL, Kasamon YL, Showel MM, Bolaños-Meade J, Huff CA, Borrello I, Matsui WH, Brodsky RA, Ambinder RF, Bettinotti MP, Fuchs EJ, Rosner GL, Jones RJ, et al. Grade II Acute GVHD and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Posttransplant Cyclophosphamide. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29055682 DOI: 10.1016/j.bbmt.2017.10.023  0.32
2017 Kosowicz JG, Lee J, Peiffer B, Guo Z, Chen J, Liao G, Hayward SD, Liu JO, Ambinder RF. Drug modulators of B cell signaling pathways and Epstein-Barr virus lytic activation. Journal of Virology. PMID 28566383 DOI: 10.1128/JVI.00747-17  0.4
2017 Kanakry CG, Bolaños-Meade J, Kasamon YL, Zahurak M, Durakovic N, Furlong T, Mielcarek M, Medeot M, Gojo I, Smith BD, Kanakry JA, Borrello IM, Brodsky RA, Gladstone DE, Huff CA, ... ... Ambinder RF, et al. Low immunosuppressive burden after HLA-matched related or unrelated BMT using post-transplantation cyclophosphamide. Blood. PMID 28049637 DOI: 10.1182/blood-2016-09-737825  0.32
2016 Klein OR, Buddenbaum J, Tucker N, Chen AR, Gamper CJ, Loeb D, Zambidis E, Llosa NJ, Huo JS, Robey N, Holuba MJ, Kasamon YL, McCurdy SR, Ambinder R, Bolaños-Meade J, et al. Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27888014 DOI: 10.1016/j.bbmt.2016.11.016  0.32
2016 McCurdy SR, Kasamon YL, Kanakry CG, Bolaños-Meade J, Tsai HL, Showel MM, Kanakry JA, Symons HJ, Gojo I, Smith BD, Bettinotti MP, Matsui WH, Dezern AE, Huff CA, Borrello I, ... ... Ambinder RF, et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with posttransplantation cyclophosphamide. Haematologica. PMID 27846611 DOI: 10.3324/haematol.2016.144139  0.32
2016 Jacene H, Crandall J, Kasamon YL, Ambinder RF, Piantadosi S, Serena D, Kasecamp W, Wahl RL. Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin Lymphoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27798787 DOI: 10.1007/s11307-016-1019-9  0.32
2016 Li L, Li C, Mao H, Du Z, Chan WY, Murray P, Luo B, Chan AT, Mok TS, Chan FK, Ambinder RF, Tao Q. Corrigendum: Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. Scientific Reports. 6: 34435. PMID 27708339 DOI: 10.1038/srep34435  0.36
2016 Crane GM, Samols MA, Morsberger LA, Yonescu R, Thiess ML, Batista DA, Ning Y, Burns KH, Vuica-Ross M, Borowitz MJ, Gocke CD, Ambinder RF, Duffield AS. Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived. Plos One. 11: e0163559. PMID 27685855 DOI: 10.1371/journal.pone.0163559  0.32
2016 Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE, Thompson J, ... ... Ambinder RF, et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the (BMT CTN) 0803/(AMC) 071 Trial. Blood. PMID 27297790 DOI: 10.1182/blood-2015-08-664706  0.4
2016 Li L, Li C, Mao H, Du Z, Chan WY, Murray P, Luo B, Chan AT, Mok TS, Chan FK, Ambinder RF, Tao Q. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. Scientific Reports. 6: 26591. PMID 27225590 DOI: 10.1038/srep26591  1
2016 Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, Valsamakis A. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. PMID 26744460 DOI: 10.1182/blood-2015-09-672030  1
2015 Bender Ignacio RA, Lee JY, Rudek MA, Dittmer DP, Ambinder RF, Krown SE. A phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi's sarcoma: AIDS Malignancy Consortium trial 059. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26689971 DOI: 10.1097/QAI.0000000000000918  1
2015 Crane GM, Powell H, Kostadinov R, Rocafort PT, Rifkin DE, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget. 6: 33849-66. PMID 26460822 DOI: 10.18632/oncotarget.5292  1
2015 Kanakry J, Ambinder R. The Biology and Clinical Utility of EBV Monitoring in Blood. Current Topics in Microbiology and Immunology. 391: 475-99. PMID 26428386 DOI: 10.1007/978-3-319-22834-1_17  1
2015 Lee HG, Kim H, Kim EJ, Park PG, Dong SM, Choi TH, Kim H, Chong CR, Liu JO, Chen J, Ambinder RF, Hayward SD, Park JH, Lee JM. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation. Oncotarget. PMID 26427042 DOI: 10.18632/oncotarget.5041  1
2015 Epeldegui M, Lee JY, Martinez AC, Widney DP, Mapantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Martinez-Maza O. Predictive value of cytokines and immune activation biomarkers in AIDS-related non-Hodgkin lymphoma treated with rituximab plus infusional EPOCH (AMC-034 trial). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26384320 DOI: 10.1158/1078-0432.CCR-14-0466  1
2015 Lombardi LR, Kanakry C, Zahurak M, Durakovic N, Bolaños-Meade J, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, et al. Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide. Leukemia & Lymphoma. 1-30. PMID 26292764 DOI: 10.3109/10428194.2015.1071488  1
2015 Kasamon YL, Bolaños-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA, Rosner GL, Brodsky RA, Perica K, Smith BD, Gladstone DE, Swinnen LJ, Showel MM, Matsui WH, Huff CA, ... ... Ambinder RF, et al. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26261255 DOI: 10.1200/JCO.2014.60.4777  1
2015 Kanakry JA, Gocke CD, Bolaños-Meade J, Gladstone DE, Swinnen LJ, Blackford AL, Fuchs EJ, Huff CA, Borrello I, Matsui WH, Brodsky RA, Rosner GL, Shanbhag S, Luznik L, Jones RJ, ... Ambinder RF, et al. Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26183076 DOI: 10.1016/j.bbmt.2015.07.012  1
2015 Epstein MM, Chang ET, Zhang Y, Fung TT, Batista JL, Ambinder RF, Zheng T, Mueller NE, Birmann BM. Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study. American Journal of Epidemiology. 182: 405-16. PMID 26182945 DOI: 10.1093/aje/kwv072  1
2015 Noonan KA, Huff CA, Davis J, Lemas MV, Fiorino S, Bitzan J, Ferguson A, Emerling A, Luznik L, Matsui W, Powell J, Fuchs E, Rosner GL, Epstein C, Rudraraju L, ... Ambinder RF, et al. Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma. Science Translational Medicine. 7: 288ra78. PMID 25995224 DOI: 10.1126/scitranslmed.aaa7014  1
2015 Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 126: 160-6. PMID 25957391 DOI: 10.1182/blood-2015-01-623900  1
2015 Linabery AM, Erhardt EB, Richardson MR, Ambinder RF, Friedman DL, Glaser SL, Monnereau A, Spector LG, Ross JA, Grufferman S. Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study. International Journal of Cancer. Journal International Du Cancer. PMID 25940226 DOI: 10.1002/ijc.29589  1
2015 McCurdy SR, Kanakry JA, Showel MM, Tsai HL, Bolaños-Meade J, Rosner GL, Kanakry CG, Perica K, Symons HJ, Brodsky RA, Gladstone DE, Huff CA, Pratz KW, Prince GT, Dezern AE, ... ... Ambinder RF, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 125: 3024-31. PMID 25814532 DOI: 10.1182/blood-2015-01-623991  1
2014 Kanakry CG, Tsai HL, Bolaños-Meade J, Smith BD, Gojo I, Kanakry JA, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Powell JD, Pratz KW, DeZern AE, ... ... Ambinder RF, et al. Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood. 124: 3817-27. PMID 25316679 DOI: 10.1182/blood-2014-07-587477  1
2014 Levy R, Ganjoo KN, Leonard JP, Vose JM, Flinn IW, Ambinder RF, Connors JM, Berinstein NL, Belch AR, Bartlett NL, Nichols C, Emmanouilides CE, Timmerman JM, Gregory SA, Link BK, et al. Active idiotypic vaccination versus control immunotherapy for follicular lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1797-803. PMID 24799467 DOI: 10.1200/JCO.2012.43.9273  1
2014 Kalu NN, Desai PJ, Shirley CM, Gibson W, Dennis PA, Ambinder RF. Nelfinavir inhibits maturation and export of herpes simplex virus 1. Journal of Virology. 88: 5455-61. PMID 24574416 DOI: 10.1128/JVI.03790-13  1
2014 Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. The American Journal of Surgical Pathology. 38: 426-32. PMID 24525514 DOI: 10.1097/PAS.0000000000000128  1
2014 Linabery AM, Erhardt EB, Fonstad RK, Ambinder RF, Bunin GR, Ross JA, Spector LG, Grufferman S. Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study. International Journal of Cancer. Journal International Du Cancer. 135: 1454-69. PMID 24523151 DOI: 10.1002/ijc.28785  1
2014 Kanakry JA, Ambinder RF. Old variables, new value: a refined IPI for DLBCL. Blood. 123: 800-1. PMID 24505063 DOI: 10.1182/blood-2013-12-540914  1
2014 Agrawal M, Kanakry J, Arnold CA, Suzman DL, Mathieu L, Kasamon YL, Gladstone DE, Ambinder RF, Ghosh N. Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma. Annals of Hematology. 93: 1245-6. PMID 24232305 DOI: 10.1007/s00277-013-1950-7  1
2014 Vendrame E, Hussain SK, Breen EC, Magpantay LI, Widney DP, Jacobson LP, Variakojis D, Knowlton ER, Bream JH, Ambinder RF, Detels R, Martínez-Maza O. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 343-9. PMID 24220912 DOI: 10.1158/1055-9965.EPI-13-0714  1
2014 Durand C, Ambinder R. Stem cell transplantation Cancers in People With Hiv and Aids: Progress and Challenges. 367-377. DOI: 10.1007/978-1-4939-0859-2_28  1
2014 Kanakry JA, Ambinder RF. Human herpesviruses: Malignant lymphoma Viral Infections of Humans: Epidemiology and Control. 933-951. DOI: 10.1007/978-1-4899-7448-8_40  1
2013 Gantt S, Casper C, Ambinder RF. Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention. Current Opinion in Oncology. 25: 495-502. PMID 23872785 DOI: 10.1097/CCO.0b013e328363dfee  1
2013 Kanakry JA, Kasamon YL, Bolaños-Meade J, Borrello IM, Brodsky RA, Fuchs EJ, Ghosh N, Gladstone DE, Gocke CD, Huff CA, Kanakry CG, Luznik L, Matsui W, Mogri HJ, Swinnen LJ, ... ... Ambinder RF, et al. Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1514-7. PMID 23871780 DOI: 10.1016/j.bbmt.2013.07.013  1
2013 Kanakry JA, Ambinder RF. EBV-related lymphomas: new approaches to treatment. Current Treatment Options in Oncology. 14: 224-36. PMID 23549980 DOI: 10.1007/s11864-013-0231-y  1
2013 Vose JM, Carter S, Burns LJ, Ayala E, Press OW, Moskowitz CH, Stadtmauer EA, Mineshi S, Ambinder R, Fenske T, Horowitz M, Fisher R, Tomblyn M. Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1662-8. PMID 23478060 DOI: 10.1200/JCO.2012.45.9453  1
2013 Hourigan CS, Forde PM, Ambinder RF, Gladstone DE. Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma. Leukemia & Lymphoma. 54: 2563-4. PMID 23445368 DOI: 10.3109/10428194.2013.780289  1
2013 Kanakry JA, Li H, Gellert LL, Lemas MV, Hsieh WS, Hong F, Tan KL, Gascoyne RD, Gordon LI, Fisher RI, Bartlett NL, Stiff P, Cheson BD, Advani R, Miller TP, ... ... Ambinder RF, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood. 121: 3547-53. PMID 23386127 DOI: 10.1182/blood-2012-09-454694  1
2013 Durand CM, Ambinder RF. Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradication. Current Opinion in Oncology. 25: 180-6. PMID 23385862 DOI: 10.1097/CCO.0b013e32835d814a  1
2013 Kanakry JA, Kasamon YL, Gocke CD, Tsai HL, Davis-Sproul J, Ghosh N, Symons H, Bolaños-Meade J, Gladstone DE, Swinnen LJ, Luznik L, Fuchs EJ, Jones RJ, Ambinder RF. Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 602-6. PMID 23370119 DOI: 10.1016/j.bbmt.2013.01.006  0.32
2013 Hussain SK, Zhu W, Chang SC, Breen EC, Vendrame E, Magpantay L, Widney D, Conn D, Sehl M, Jacobson LP, Bream JH, Wolinsky S, Rinaldo CR, Ambinder RF, Detels R, et al. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 295-307. PMID 23250934 DOI: 10.1158/1055-9965.EPI-12-1122  1
2013 Zeidan A, Bolaños-Meade J, Kasamon Y, Aoki J, Borowitz M, Swinnen L, Symons H, Luznik L, Fuchs E, Jones R, Ambinder R. Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma. Leukemia & Lymphoma. 54: 655-7. PMID 22845310 DOI: 10.3109/10428194.2012.717082  1
2013 Kasamon YL, Brodsky RA, Borowitz MJ, Ambinder RF, Crilley PA, Cho SY, Tsai HL, Smith BD, Gladstone DE, Carraway HE, Huff CA, Matsui WH, Bolaños-Meade J, Jones RJ, Swinnen LJ. Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia. Leukemia & Lymphoma. 54: 483-90. PMID 22835045 DOI: 10.3109/10428194.2012.715346  0.32
2012 Gellert LL, Kasamon YL, Lemas MV, Toure MV, Ambinder RF. Cell-free EBV DNA in Hodgkin lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 7. PMID 28142412 DOI: 10.1200/jco.2012.30.30_suppl.7  0.32
2012 Wang Z, Li L, Su X, Gao Z, Srivastava G, Murray PG, Ambinder R, Tao Q. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas. Journal of Translational Medicine. 10: 209. PMID 23050586 DOI: 10.1186/1479-5876-10-209  1
2012 Levin LI, Chang ET, Ambinder RF, Lennette ET, Rubertone MV, Mann RB, Borowitz M, Weir EG, Abbondanzo SL, Mueller NE. Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma. Blood. 120: 3750-5. PMID 22972983 DOI: 10.1182/blood-2011-12-390823  1
2012 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, et al. Hodgkin lymphoma, version 2.2012: Featured updates to the NCCN guidelines Jnccn Journal of the National Comprehensive Cancer Network. 10: 589-597. PMID 22570290  1
2012 Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins. Bmc Cancer. 12: 125. PMID 22458933 DOI: 10.1186/1471-2407-12-125  1
2012 Shamay M, Liu J, Li R, Liao G, Shen L, Greenway M, Hu S, Zhu J, Xie Z, Ambinder RF, Qian J, Zhu H, Hayward SD. A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. Journal of Virology. 86: 5179-91. PMID 22379092 DOI: 10.1128/JVI.00169-12  1
2012 Shamay M, Hand N, Lemas MV, Koon HB, Krown SE, Wrangle J, Desai P, Ramos JC, Ambinder RF. CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA. The Journal of Infectious Diseases. 205: 1095-9. PMID 22357696 DOI: 10.1093/infdis/jis032  1
2012 Kasamon YL, Jacene HA, Gocke CD, Swinnen LJ, Gladstone DE, Perkins B, Link BK, Popplewell LL, Habermann TM, Herman JM, Matsui WH, Jones RJ, Ambinder RF. Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. Blood. 119: 4129-32. PMID 22343727 DOI: 10.1182/blood-2012-01-402792  1
2012 Durand CM, Ghiaur G, Siliciano JD, Rabi SA, Eisele EE, Salgado M, Shan L, Lai JF, Zhang H, Margolick J, Jones RJ, Gallant JE, Ambinder RF, Siliciano RF. HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy. The Journal of Infectious Diseases. 205: 1014-8. PMID 22275402 DOI: 10.1093/infdis/jir884  1
2012 Durand C, Ambinder R, Blankson J, Forman S. HIV-1 and hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: S172-6. PMID 22226103 DOI: 10.1016/j.bbmt.2011.10.027  1
2012 Hwang AE, Hamilton AS, Cockburn MG, Ambinder R, Zadnick J, Brown EE, Mack TM, Cozen W. Evidence of genetic susceptibility to infectious mononucleosis: a twin study. Epidemiology and Infection. 140: 2089-95. PMID 22152594 DOI: 10.1017/S0950268811002457  1
2011 Bennani-Baiti N, Daw HA, Cotta C, Martin P, Mitchell KW, Ambinder RF, Macklis R, Pollock R, Spiro T. Low-grade follicular lymphoma of the small intestine: a challenge for management. Seminars in Oncology. 38: 714-20. PMID 22082756 DOI: 10.1053/j.seminoncol.2011.08.002  1
2011 Li R, Zhu J, Xie Z, Liao G, Liu J, Chen MR, Hu S, Woodard C, Lin J, Taverna SD, Desai P, Ambinder RF, Hayward GS, Qian J, Zhu H, et al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host & Microbe. 10: 390-400. PMID 22018239 DOI: 10.1016/j.chom.2011.08.013  1
2011 Zheng D, Wan J, Cho YG, Wang L, Chiou CJ, Pai S, Woodard C, Zhu J, Liao G, Martinez-Maza O, Qian J, Zhu H, Hayward GS, Ambinder RF, Hayward SD. Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray. The Journal of Infectious Diseases. 204: 1683-91. PMID 21990424 DOI: 10.1093/infdis/jir645  1
2011 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, et al. Hodgkin lymphoma. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 1020-58. PMID 21917626  1
2011 Hobbs RF, Baechler S, Fu DX, Esaias C, Pomper MG, Ambinder RF, Sgouros G. A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy. Medical Physics. 38: 2892-903. PMID 21815364 DOI: 10.1118/1.3576051  1
2011 Gladstone DE, Bolaños-Meade J, Huff CA, Zahurak M, Flinn I, Borrello I, Luznik L, Fuchs E, Kasamon Y, Matsui W, Powell J, Levitsky H, Brodsky RA, Ambinder R, Jones RJ, et al. High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas. Leukemia & Lymphoma. 52: 2076-81. PMID 21756035 DOI: 10.3109/10428194.2011.594191  1
2011 Shirley CM, Ambinder RF. When differentiation goes viral. Blood. 117: 5790-1. PMID 21636716 DOI: 10.1182/blood-2011-04-344135  1
2011 Rudek MA, Flexner C, Ambinder RF. Use of antineoplastic agents in patients with cancer who have HIV/AIDS. The Lancet. Oncology. 12: 905-12. PMID 21570912 DOI: 10.1016/S1470-2045(11)70056-0  1
2011 Gaillard S, Dinoso JB, Marsh JA, DeZern AE, O'Connell KA, Spivak AM, Alwood K, Durand CM, Ambinder RF, Blankson JN. Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 51: 195-8. PMID 21550842 DOI: 10.1016/j.jcv.2011.04.002  1
2011 Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1303-14. PMID 21527584 DOI: 10.1158/1055-9965.EPI-11-0037  1
2011 Shirley CM, Chen J, Shamay M, Li H, Zahnow CA, Hayward SD, Ambinder RF. Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. Blood. 117: 6297-303. PMID 21447826 DOI: 10.1182/blood-2011-01-332379  1
2011 He J, Wu J, Jiao Y, Wagner-Johnston N, Ambinder RF, Diaz LA, Kinzler KW, Vogelstein B, Papadopoulos N. IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients. Oncotarget. 2: 178-85. PMID 21399237  1
2011 Wagner-Johnston ND, Gellert L, Gocke CD, Lemas VM, Lee J, Martínez-Maza O, Ambinder RF. Clonal immunoglobulin DNA in the plasma of patients with AIDS lymphoma. Blood. 117: 4860-2. PMID 21389324 DOI: 10.1182/blood-2010-12-324657  1
2011 Beachler DC, Gellert LL, Jacobson LP, Ambinder RF, Breen EC, Martínez-Maza O, Rabkin CS, Rabkin CC, Kaslow RA, D'Souza G. Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk. Journal of Acquired Immune Deficiency Syndromes (1999). 56: 188-92. PMID 21116187 DOI: 10.1097/QAI.0b013e3181ff976b  1
2011 Kasamon YL, Jones RJ, Gocke CD, Blackford AL, Seifter EJ, Davis-Sproul JM, Gore SD, Ambinder RF. Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 365-73. PMID 20655387 DOI: 10.1016/j.bbmt.2010.07.007  1
2010 Ambinder RF. Mystery of the missing target. Blood. 116: 3691-2. PMID 21071613 DOI: 10.1182/blood-2010-09-300590  1
2010 Ambinder RF, Bhatia K, Martinez-Maza O, Mitsuyasu R. Cancer biomarkers in HIV patients. Current Opinion in Hiv and Aids. 5: 531-7. PMID 20978397 DOI: 10.1097/COH.0b013e32833f327e  1
2010 Shamay M, Greenway M, Liao G, Ambinder RF, Hayward SD. De novo DNA methyltransferase DNMT3b interacts with NEDD8-modified proteins. The Journal of Biological Chemistry. 285: 36377-86. PMID 20847044 DOI: 10.1074/jbc.M110.155721  1
2010 Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 116: 3969-77. PMID 20564162 DOI: 10.1002/cncr.25362  1
2010 Wong HL, Breen EC, Pfeiffer RM, Aissani B, Martinson JJ, Margolick JB, Kaslow RA, Jacobson LP, Ambinder RF, Chanock S, Martínez-Maza O, Rabkin CS. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. Aids (London, England). 24: 1025-33. PMID 20299965 DOI: 10.1097/QAD.0b013e328332d5b1  1
2010 Luznik L, Bolaños-Meade J, Zahurak M, Chen AR, Smith BD, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD, Kasamon Y, Goodman SN, Hess A, Levitsky HI, Ambinder RF, et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood. 115: 3224-30. PMID 20124511 DOI: 10.1182/blood-2009-11-251595  1
2010 Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, et al. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 115: 3008-16. PMID 20023215 DOI: 10.1182/blood-2009-08-231613  1
2010 Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith BD, Matsui WH, Goodman SN, Ambinder RF, Jones RJ. High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up. Blood. 115: 2136-41. PMID 20018919 DOI: 10.1182/blood-2009-06-225375  1
2010 Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai HL, Bolaños-Meade J, Morris LE, Crilley PA, O'Donnell PV, Rossiter N, Huff CA, Brodsky RA, Matsui WH, Swinnen LJ, Borrello I, ... ... Ambinder RF, et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 482-9. PMID 19925877 DOI: 10.1016/j.bbmt.2009.11.011  1
2010 Kasamon YL, Jones RJ, Brodsky RA, Fuchs EJ, Matsui W, Luznik L, Powell JD, Blackford AL, Goodrich A, Gocke CD, Abrams RA, Ambinder RF, Flinn IW. Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 1203-10. PMID 19880437 DOI: 10.1093/annonc/mdp484  1
2009 Lechowicz M, Dittmer DP, Lee JY, Krown SE, Wachsman W, Aboulafia D, Dezube BJ, Ratner L, Said J, Ambinder RF. Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1946-9. PMID 19911999 DOI: 10.1086/648447  1
2009 Lin J, Gilbert J, Rudek MA, Zwiebel JA, Gore S, Jiemjit A, Zhao M, Baker SD, Ambinder RF, Herman JG, Donehower RC, Carducci MA. A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6241-9. PMID 19789320 DOI: 10.1158/1078-0432.CCR-09-0567  1
2009 Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, Jacobson LP, Rabkin CS, Ambinder RF, Martinez-Maza O, Kaslow RA. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 170-9. PMID 19654554 DOI: 10.1097/QAI.0b013e3181b017d5  1
2009 Ambinder RF. The same but different: Autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection Bone Marrow Transplantation. 44: 1-5. PMID 19448679 DOI: 10.1038/bmt.2009.105  1
2009 Lin L, Lee JY, Kaplan LD, Dezube BJ, Noy A, Krown SE, Levine AM, Yu Y, Hayward GS, Ambinder RF. Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2496-502. PMID 19349542 DOI: 10.1200/JCO.2008.20.1707  1
2009 Chang ET, Birmann BM, Kasperzyk JL, Conti DV, Kraft P, Ambinder RF, Zheng T, Mueller NE. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 976-86. PMID 19223558 DOI: 10.1158/1055-9965.EPI-08-1130  1
2009 Ratner L, Harrington W, Feng X, Grant C, Jacobson S, Noy A, Sparano J, Lee J, Ambinder R, Campbell N, Lairmore M. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. Plos One. 4: e4420. PMID 19204798 DOI: 10.1371/journal.pone.0004420  1
2009 Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M, Lemas MV, Brennan S, Ambinder RF, Matsui W. Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood. 113: 5920-6. PMID 19188663 DOI: 10.1182/blood-2008-11-189688  1
2009 Kasamon YL, Wahl RL, Ziessman HA, Blackford AL, Goodman SN, Fidyk CA, Rogers KM, Bolaños-Meade J, Borowitz MJ, Ambinder RF, Jones RJ, Swinnen LJ. Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 242-8. PMID 19167684 DOI: 10.1016/j.bbmt.2008.11.026  1
2009 Fuchs EJ, Luznik L, Bolaños-Meade J, Miller CB, Brodsky RA, Ambinder RF, Jones RJ. Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT. Bone Marrow Transplantation. 43: 969-70. PMID 19139737 DOI: 10.1038/bmt.2008.416  1
2009 Jones RJ, Gocke CD, Ambinder RF, Matsui W. Hodgkin lymphoma stem cells Blood. 114: 3971-3972. DOI: 10.1182/blood-2009-08-237545  1
2009 Hsieh WS, Ambinder RF. Epstein-Barr Virus Infection Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. 1410-1418. DOI: 10.1002/9781444303537.ch93  1
2008 Fu DX, Foss CA, Nimmagadda S, Ambinder RF, Pomper MG. Imaging virus-associated cancer. Current Pharmaceutical Design. 14: 3048-65. PMID 18991718 DOI: 10.2174/138161208786404371  1
2008 Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nature Medicine. 14: 1118-22. PMID 18776891 DOI: 10.1038/nm.1864  1
2008 Glaser SL, Gulley ML, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Anton-Culver H, Ambinder RF. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. International Journal of Cancer. Journal International Du Cancer. 123: 1499-507. PMID 18646185 DOI: 10.1002/ijc.23741  1
2008 Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, et al. Hodgkin disease/lymphoma. Journal of the National Comprehensive Cancer Network : Jnccn. 6: 594-622. PMID 18597713  1
2008 Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF, Huff CA, Matsui W, Bolaños-Meade J, Borrello I, Powell JD, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 641-50. PMID 18489989 DOI: 10.1016/j.bbmt.2008.03.005  1
2008 Perkins EM, Anacker D, Davis A, Sankar V, Ambinder RF, Desai P. Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids. Journal of Virology. 82: 7201-11. PMID 18463150 DOI: 10.1128/JVI.00423-08  1
2008 Wagner-Johnston ND, Ambinder RF. Blood and marrow transplant for lymphoma patients with HIV/AIDS. Current Opinion in Oncology. 20: 201-5. PMID 18300771 DOI: 10.1097/CCO.0b013e3282f5101e  1
2008 Warlick ED, O'Donnell PV, Borowitz M, Grupka N, Decloe L, Garrett-Mayer E, Borrello I, Brodsky R, Fuchs E, Huff CA, Luznik L, Matsui W, Ambinder R, Jones RJ, Smith BD. Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes. Leukemia Research. 32: 1439-47. PMID 18261793 DOI: 10.1016/j.leukres.2007.12.017  1
2008 Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 59-66. PMID 18158962 DOI: 10.1016/j.bbmt.2007.03.014  1
2008 Kasamon YL, Ambinder RF. Immunotherapies for Hodgkin's lymphoma. Critical Reviews in Oncology/Hematology. 66: 135-44. PMID 18023356 DOI: 10.1016/j.critrevonc.2007.10.001  1
2008 Ambinder RF. Hodgkin twins: Double good, double trouble Blood. 111: 3310.  1
2007 Wagner-Johnston ND, Ambinder RF. Epstein-Barr virus-related lymphoproliferative disorders. Current Hematologic Malignancy Reports. 2: 249-54. PMID 20425377 DOI: 10.1007/s11899-007-0034-y  1
2007 Ying J, Li H, Murray P, Gao Z, Chen YW, Wang Y, Lee KY, Chan AT, Ambinder RF, Srivastava G, Tao Q. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas. Epigenetics. 2: 15-21. PMID 17965626  0.4
2007 Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R, Kasamon YL, Swinnen LJ, Flinn IW, Ambinder RF, Jones RJ, et al. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1185-91. PMID 17889355 DOI: 10.1016/j.bbmt.2007.06.011  1
2007 Berdeja JG, Hess A, Lucas DM, O'Donnell P, Ambinder RF, Diehl LF, Carter-Brookins D, Newton S, Flinn IW. Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2392-9. PMID 17438098 DOI: 10.1158/1078-0432.CCR-06-1860  1
2007 Ying J, Gao Z, Li H, Srivastava G, Murray PG, Goh HK, Lim CY, Wang Y, Marafioti T, Mason DY, Ambinder RF, Chan AT, Tao Q. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. British Journal of Haematology. 136: 829-32. PMID 17341268 DOI: 10.1111/j.1365-2141.2007.06512.x  0.4
2007 Fu DX, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, Chong JM, Ambinder RF, Pomper MG. Virus-associated tumor imaging by induction of viral gene expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1453-8. PMID 17332288 DOI: 10.1158/1078-0432.CCR-06-2295  1
2007 Ambinder RF, Cesarman E. Clinical and pathological aspects of EBV and KSHV infection Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 885-903. DOI: 10.1017/CBO9780511545313.051  1
2006 Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 965-72. PMID 16920563 DOI: 10.1016/j.bbmt.2006.05.018  1
2006 Huff CA, Fuchs EJ, Smith BD, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH, Vogelsang GB, Griffin CA, Luznik L, Jones RJ. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 414-21. PMID 16545725 DOI: 10.1016/j.bbmt.2005.11.520  1
2006 Krown SE, Lee JY, Lin L, Fischl MA, Ambinder R, Von Roenn JH. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 149-53. PMID 16394845 DOI: 10.1097/01.qai.0000194237.15831.23  1
2006 Ambinder RF. Hiding in plain sight Blood. 108: 2891. DOI: 10.1182/blood-2006-09-040824  1
2006 Lemas MV, Ambinder RF. The kiss that scars Blood. 108: 8. DOI: 10.1182/blood-2006-04-016261  1
2005 Ambinder RF, Lin L. Mononucleosis in the laboratory. The Journal of Infectious Diseases. 192: 1503-4. PMID 16206063 DOI: 10.1086/491746  1
2005 Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7604-13. PMID 16186595 DOI: 10.1200/JCO.2005.02.6310  1
2005 Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors Clinical Cancer Research. 11: 6442-6449. PMID 16166418 DOI: 10.1158/1078-0432.CCR-05-0267  1
2005 Kasamon YL, Ambinder RF. AIDS-related primary central nervous system lymphoma Hematology/Oncology Clinics of North America. 19: 665-687. PMID 16083829 DOI: 10.1016/j.hoc.2005.05.004  1
2005 Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 106: 1538-43. PMID 15914552 DOI: 10.1182/blood-2005-04-1437  1
2005 Glaser SL, Keegan TH, Clarke CA, Trinh M, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF. Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women. International Journal of Cancer. Journal International Du Cancer. 115: 599-605. PMID 15700307 DOI: 10.1002/ijc.20787  1
2005 Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ, Morrison C, Smith BD, Flinn IW. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 93-100. PMID 15682069 DOI: 10.1016/j.bbmt.2004.09.009  1
2005 Kasamon YL, Jones RJ, Diehl LF, Nayer H, Borowitz MJ, Garrett-Mayer E, Ambinder RF, Abrams RA, Zhang Z, Flinn IW. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 39-46. PMID 15625543 DOI: 10.1016/j.bbmt.2004.09.007  1
2004 Meyer RM, Ambinder RF, Stroobants S. Hodgkin's lymphoma: evolving concepts with implications for practice. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 184-202. PMID 15561683 DOI: 10.1182/asheducation-2004.1.184  1
2004 Orlowski RZ, Mills SR, Hartley EE, Ye X, Piantadosis S, Ambinder RF, Gore SD, Miller CB. Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia Leukemia and Lymphoma. 45: 2215-2219. PMID 15512809 DOI: 10.1080/10428190410001733763  1
2004 Glaser SL, Gulley ML, Borowitz MJ, Craig FE, Mann RB, Stewart SL, Shema SJ, Ambinder RF. Inter- and intra-observer reliability of Epstein-Barr virus detection in Hodgkin lymphoma using histochemical procedures. Leukemia & Lymphoma. 45: 489-97. PMID 15160910 DOI: 10.1080/1042819032000141310  1
2004 Glaser SL, Keegan TH, Clarke CA, Darrow LA, Gomez SL, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF. Smoking and Hodgkin lymphoma risk in women United States. Cancer Causes & Control : Ccc. 15: 387-97. PMID 15141139 DOI: 10.1023/B:CACO.0000027497.00558.e2  1
2004 Sparano JA, Lee S, Chen MG, Nazeer T, Einzig A, Ambinder RF, Henry DH, Manalo J, Li T, Von Roenn JH. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1491-500. PMID 15084622 DOI: 10.1200/JCO.2004.08.195  1
2004 Chan AT, Tao Q, Robertson KD, Flinn IW, Mann RB, Klencke B, Kwan WH, Leung TW, Johnson PJ, Ambinder RF. Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1373-81. PMID 15007085 DOI: 10.1200/JCO.2004.04.185  1
2003 Ambinder RF. Epstein-Barr Virus-Associated Lymphoproliferative Disorders Reviews in Clinical and Experimental Hematology. 7: 362-374. PMID 15129648  1
2003 Huang J, Chen H, Hutt-Fletcher L, Ambinder RF, Hayward SD. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. Journal of Virology. 77: 13267-74. PMID 14645583 DOI: 10.1128/JVI.77.24.13267-13274.2003  1
2003 Ambinder R. Infection and lymphoma New England Journal of Medicine. 349: 1309-1311. PMID 14523136 DOI: 10.1056/NEJMp030083  1
2003 Song DY, Jones RJ, Welsh JS, Haulk TL, Korman LT, Noga S, Goodman S, Herman M, Mann R, Marcellus D, Vogelsang G, Ambinder RF, Abrams RA. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. International Journal of Radiation Oncology, Biology, Physics. 57: 166-71. PMID 12909229 DOI: 10.1016/S0360-3016(03)00508-X  1
2003 Ambinder RF. Posttransplant lymphoproliferative disease: Pathogenesis, monitoring, and therapy Current Oncology Reports. 5: 359-363. PMID 12895385  1
2003 Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Ambinder RF. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the greater San Francisco bay area, 1988-1998 Cancer. 98: 300-309. PMID 12872349 DOI: 10.1002/cncr.11459  1
2003 Ambinder RF. Viruses as potential targets for therapy in HIV-associated malignancies Hematology/Oncology Clinics of North America. 17: 697-702. PMID 12852651  1
2002 Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. Journal of Medical Virology. 68: 370-7. PMID 12226824 DOI: 10.1002/jmv.10213  1
2002 Carraway H, Ambinder RF. Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus Current Opinion in Oncology. 14: 543-545. PMID 12192275 DOI: 10.1097/00001622-200209000-00012  1
2002 Lechowicz MJ, Lin L, Ambinder RF. Epstein-Barr virus DNA in body fluids. Current Opinion in Oncology. 14: 533-7. PMID 12192273 DOI: 10.1097/00001622-200209000-00010  1
2002 Tao Q, Yang J, Huang H, Swinnen LJ, Ambinder RF. Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: Implications for immune therapy American Journal of Pathology. 160: 1839-1845. PMID 12000735  1
2002 Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM, Alcendor DJ, Zong JC, Ambinder RF, Hayward GS. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. Journal of Virology. 76: 3421-39. PMID 11884567 DOI: 10.1128/JVI.76.7.3421-3439.2002  1
2002 Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ, Ambinder RF. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma American Journal of Clinical Pathology. 117: 259-267. PMID 11863222 DOI: 10.1309/MMAU-0QYH-7BHA-W8C2  1
2001 Berdeja JG, Jones RJ, Zahurak ML, Piantadosi S, Abrams RA, Borowitz MJ, Vogelsang GB, Noga SJ, Ambinder RF, Flinn IW. Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 7: 561-7. PMID 11760088  1
2001 Akpek G, Ambinder RF, Piantadosi S, Abrams RA, Brodsky RA, Vogelsang GB, Zahurak ML, Fuller D, Miller CB, Noga SJ, Fuchs E, Flinn IW, O'Donnell P, Seifter EJ, Mann RB, et al. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 4314-21. PMID 11731514  1
2001 Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas. Human Pathology. 32: 963-9. PMID 11567226 DOI: 10.1053/hupa.2001.27114  1
2001 Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting European Journal of Cancer. 37: 1209-1216. PMID 11423253 DOI: 10.1016/S0959-8049(01)00123-X  1
2001 Moore SM, Cannon JS, Tanhehco YC, Hamzeh FM, Ambinder RF. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrobial Agents and Chemotherapy. 45: 2082-91. PMID 11408227 DOI: 10.1128/AAC.45.7.2082-2091.2001  1
2001 Murray PG, Flavell JR, Baumforth KR, Toomey SM, Lowe D, Crocker J, Ambinder RF, Young LS. Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease. The Journal of Pathology. 194: 158-64. PMID 11400143 DOI: 10.1002/path.873  1
2001 Ciufo DM, Cannon JS, Poole LJ, Wu FY, Murray P, Ambinder RF, Hayward GS. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. Journal of Virology. 75: 5614-26. PMID 11356969 DOI: 10.1128/JVI.75.12.5614-5626.2001  1
2001 Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, Scadden D, Kaplan L, Ambinder R, Levine A, Harrington W, Grochow L, Flexner C, Tan B, Straus D. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy Journal of Clinical Oncology. 19: 2171-2178. PMID 11304769  1
2001 Clarke CA, Glaser SL, Dorfman RF, Mann R, Digiuseppe JA, Prehn AW, Ambinder RF. Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women Cancer. 91: 1579-1587. PMID 11301409 DOI: 10.1002/1097-0142(20010415)91:8<1579::AID-CNCR1169>3.0.CO;2-L  1
2001 Chen H, Lee JM, Zong Y, Borowitz M, Ng MH, Ambinder RF, Hayward SD. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. Journal of Virology. 75: 2929-37. PMID 11222718 DOI: 10.1128/JVI.75.6.2929-2937.2001  1
2001 Ambinder RF, Sparano JA. Primary central nervous system lymphoma Cancer Treatment and Research. 104: 231-246. PMID 11191129  1
2000 Flinn IW, O'Donnell PV, Goodrich A, Vogelsang G, Abrams R, Noga S, Marcellus D, Borowitz M, Jones R, Ambinder RF. Immunotherapy with Rituximab during Peripheral Blood Stem Cell Transplantation for Non-Hodgkin's Lymphoma Biology of Blood and Marrow Transplantation. 6: 628-632. PMID 11128813  1
2000 Yang J, Tao Q, Flinn IW, Murray PG, Post LE, Ma H, Piantadosi S, Caligiuri MA, Ambinder RF. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response Blood. 96: 4055-4063. PMID 11110673  1
2000 Cannon JS, Ciufo D, Hawkins AL, Griffin CA, Borowitz MJ, Hayward GS, Ambinder RF. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. Journal of Virology. 74: 10187-93. PMID 11024147 DOI: 10.1128/JVI.74.21.10187-10193.2000  1
2000 Ambinder RF. New controversies and new directions Current Opinion in Oncology. 12: 435-437. PMID 10975550 DOI: 10.1097/00001622-200009000-00008  1
2000 Flinn IW, Goodman SN, Post L, Jamison J, Miller CB, Gore S, Diehl L, Willis C, Ambinder RF, Byrd JC. A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL Annals of Oncology. 11: 691-695. PMID 10942057 DOI: 10.1023/A:1008361914894  1
2000 Flinn IW, Byrd JC, Morrison C, Jamison J, Diehl LF, Murphy T, Piantadosi S, Seifter E, Ambinder RF, Vogelsang G, Grever MR. Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies Blood. 96: 71-75. PMID 10891432  1
2000 Ambinder RF. Gammaherpesviruses and 'hit-and-run' oncogenesis American Journal of Pathology. 156: 1-3. PMID 10623645  1
2000 Yang J, Lemas VM, Flinn IW, Krone C, Ambinder RF. Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens Blood. 95: 241-248. PMID 10607708  1
1999 Hsieh WS, Lemas MV, Ambinder RF. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease Transplant Infectious Disease : An Official Journal of the Transplantation Society. 1: 204-212. PMID 11428990  1
1999 Schroeder JR, Saah AJ, Ambinder RF, Martinez-Maza O, Crabb Breen E, Variakojis D, Margolick JB, Jacobson LP, Rowe DT, Hoover DR. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue Clinical Immunology. 93: 239-244. PMID 10600334 DOI: 10.1006/clim.1999.4793  1
1999 Schroeder JR, Saah AJ, Hoover DR, Margolick JB, Ambinder RF, Martinez-Maza O, Breen EC, Jacobson LP, Variakojis D, Rowe DT, Armenian HK. Serum soluble CD23 level correlates with subsequent development of AIDS- related non-Hodgkin's lymphoma Cancer Epidemiology Biomarkers and Prevention. 8: 979-984. PMID 10566552  1
1999 Ambinder RF, Robertson KD, Tao Q. DNA methylation and the Epstein-Barr virus Seminars in Cancer Biology. 9: 369-375. PMID 10547345 DOI: 10.1006/scbi.1999.0137  1
1999 Tao Q, Ambinder RF. Lack of Kaposi's sarcoma - Associated virus (KSHV) and detection of human herpes virus 6 and 7 by PCR in African Burkitt's lymphoma from HIV- negative patients [1] Human Pathology. 30: 1269-1270. PMID 10534180  1
1999 Cannon JS, Nicholas J, Orenstein JM, Mann RB, Murray PG, Browning PJ, DiGiuseppe JA, Cesarman E, Hayward GS, Ambinder RF. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. The Journal of Infectious Diseases. 180: 824-8. PMID 10438372 DOI: 10.1086/314956  1
1999 Qian T, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF. Methylation status of the Epstein-Barr virus major latent promoter C in latrogenic B cell lymphoproliferative disease: Application of PCR-based analysis American Journal of Pathology. 155: 619-625. PMID 10433954  1
1999 Chen H, Lee JM, Wang Y, Huang DP, Ambinder RF, Hayward SD. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Proceedings of the National Academy of Sciences of the United States of America. 96: 9339-44. PMID 10430944 DOI: 10.1073/pnas.96.16.9339  1
1999 Poole LJ, Zong JC, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, Orenstein JM, Reitz MS, Hayward GS. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. Journal of Virology. 73: 6646-60. PMID 10400762  1
1999 Cannon JS, Hamzeh F, Moore S, Nicholas J, Ambinder RF. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. Journal of Virology. 73: 4786-93. PMID 10233939  1
1999 Chen H, Smith P, Ambinder RF, Hayward SD. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood. 93: 3026-32. PMID 10216099  1
1999 Echavarria MS, Ray SC, Ambinder R, Dumler JS, Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: Hemorrhagic cystitis as a presenting manifestation of disseminated disease Journal of Clinical Microbiology. 37: 686-689. PMID 9986832  1
1999 Ambinder RF, Lemas MV, Moore S, Yang J, Fabian D, Krone C. Epstein-Barr virus and lymphoma Cancer Treatment and Research. 99: 27-45. PMID 9891862  1
1998 Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Epstein-Barr virus in Hodgkin's disease: Correlation of risk factors and disease characteristics with molecular evidence of viral infection Cancer Epidemiology Biomarkers and Prevention. 7: 1117-1121. PMID 9865430  1
1998 Murray PG, Constandinou CM, Crocker J, Young LS, Ambinder RF. Analysis of major histocompatibility complex class I, tap expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease Blood. 92: 2477-2483. PMID 9746788  1
1998 Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive Journal of Virology. 72: 7075-7083. PMID 9696800  1
1998 Orentas RJ, Lemas MV, Mullin MJ, Colombani PM, Schwarz K, Ambinder R. Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors. Journal of Hematotherapy. 7: 257-61. PMID 9621259  1
1998 Tao Q, Ambinder RF, Swinnen LJ. Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance The American Journal of Pathology. 152: 1398-1399. PMID 9588909  1
1998 Tsai ST, Jin YT, Mann RB, Ambinder RF. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma Cancer. 82: 1449-1453. PMID 9554519 DOI: 10.1002/(SICI)1097-0142(19980415)82:8<1449::AID-CNCR3>3.0.CO;2-4  1
1998 Glashr SL, Ambinder RF, Digiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers International Journal of Cancer. 75: 555-558. PMID 9466655 DOI: 10.1002/(SICI)1097-0215(19980209)75:4<555::AID-IJC10>3.0.CO;2-8  1
1998 Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue Blood. 91: 1373-1381. PMID 9454768  1
1997 Eigenmann PA, Ambinder RF, Lederman HM. Chronic sinusitis with acquired immunoglobulin A (IgA) deficiency after bone marrow transplantation Otolaryngology - Head and Neck Surgery. 117. PMID 9419155 DOI: 10.1016/S0194-5998(97)70109-8  1
1997 Robertson KD, Ambinder RF. Methylation of the Epstein-Barr virus genome in normal lymphocytes Blood. 90: 4480-4484. PMID 9373258  1
1997 Gillison ML, Ambinder RF. Human herpesvirus-8 Current Opinion in Oncology. 9: 440-449. PMID 9327222  1
1997 Robertson KD, Ambinder RF. Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: Application of the methylation cassette assay to the Epstein-Barr virus major latency promoter Journal of Virology. 71: 6445-6454. PMID 9261362  1
1997 Abrams RA, Liu PJ, Ambinder RF, Haulk TL, Korman LT, Herman MG, Jones RJ. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation. Radiology. 203: 865-70. PMID 9169718 DOI: 10.1148/radiology.203.3.9169718  1
1997 Sing AP, Ambinder RF, Hong DJ, Jensen M, Batten W, Petersdorf E, Greenberg PD. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV+ Hodgkin's disease Blood. 89: 1978-1986. PMID 9058719  1
1996 Flinn IW, Ambinder RF. AIDS primary central nervous system lymphoma Current Opinion in Oncology. 8: 373-376. PMID 9026061  1
1996 Ambinder RF, Robertson KD, Moore SM, Yang J. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma. Seminars in Cancer Biology. 7: 217-26. PMID 8946606 DOI: 10.1006/scbi.1996.0029  1
1996 Lin AY, Kingma DW, Lennette ET, Fears TR, Whitehouse JM, Ambinder RF, Jaffe ES, Levine PH, Tucker MA. Epstein-Barr virus and familial Hodgkin's disease Blood. 88: 3160-3165. PMID 8874216  1
1996 Robertson KD, Manns A, Swinnen LJ, Zong JC, Gulley ML, Ambinder RF. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease Blood. 88: 3129-3136. PMID 8874213  1
1996 Ambinder R. AIDS oncology emerges as a clinical discipline Current Opinion in Oncology. 8: 371-372.  1
1995 Ambinder RF. Cancer in AIDS Current Opinion in Oncology. 7: 427-428. PMID 8541387  1
1995 Caldas C, Ambinder R. Epstein-Barr virus and bone marrow transplantation Current Opinion in Oncology. 7: 102-106. PMID 7756374  1
1995 Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, Arthur RR, Jones RJ. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 1103-9. PMID 7738616  1
1995 DiGiuseppe JA, Wu TC, Zehnbauer BA, McDowell PR, Barletta JM, Ambinder RF, Mann RB. Epsiein-Barr virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype Modern Pathology. 8: 553-559. PMID 7675777  1
1995 Murray PG, Deacon E, Young LS, Barletta JM, Mann RB, Ambinder RF, Rowlands DC, Jones EL, Ramsay AD, Crocker J. Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistry. Hematologic Pathology. 9: 17-26. PMID 7628995  1
1995 Siebert JD, Ambinder RF, Napoli VM, Quintanilla-Martinez L, Banks PM, Gulley ML. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus Human Pathology. 26: 1191-1195. PMID 7590691 DOI: 10.1016/0046-8177(95)90192-2  1
1995 Robertson KD, Hayward SD, Ling PD, Samid D, Ambinder RF. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Molecular and Cellular Biology. 15: 6150-9. PMID 7565767  1
1994 Kingma DW, Medeiros LJ, Barletta J, Raffeld M, Mann RB, Ambinder RF, Jaffe ES. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease American Journal of Surgical Pathology. 18: 48-61. PMID 8279628  1
1994 Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens American Journal of Pathology. 145: 239-252. PMID 8053485  1
1994 Ambinder RF, Mann RB. Epstein-Barr-encoded RNA in situ hybridization: Diagnostic applications Human Pathology. 25: 602-605. PMID 8013952 DOI: 10.1016/0046-8177(94)90227-5  1
1994 Robertson KD, Barletta J, Samid D, Ambinder RF. Pharmacologic activation of expression of immunodominant viral antigens: A new strategy for the treatment of Epstein-Barr-virus-associated malignancies Current Topics in Microbiology and Immunology. 194: 145-154. PMID 7534666  1
1994 MacMahon EME, Ambinder RF. EBER in situ hybridisation: Sensitive detection of latent Epstein-Barr virus in individual cells Reviews in Medical Virology. 4: 251-260. DOI: 10.1002/rmv.1980040404  1
1993 Ryon JJ, Hayward SD, MacMahon EM, Mann RB, Ling Y, Charache P, Phelan JA, Miller G, Ambinder RF. In situ detection of lytic Epstein-Barr virus infection: expression of the NotI early gene and viral interleukin-10 late gene in clinical specimens. The Journal of Infectious Diseases. 168: 345-51. PMID 8393057  1
1993 Barletta JM, Kingma DW, Ling Y, Charache P, Mann RB, Ambinder RF. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection Molecular and Cellular Probes. 7: 105-109. PMID 8391639 DOI: 10.1006/mcpr.1993.1014  1
1993 Stratford May W, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Griffin CA, Jones RJ, Miller CB, Mellits ED, Vogelsang GB, Wagner JE, Wingard JR, Yeager AM, Santos GW. BMT for severe aplastic anemia using cyclosporine Bone Marrow Transplantation. 11: 459-464. PMID 8334426  1
1992 Wagner JE, Zahurak M, Piantadosi S, Geller RB, Vogelsang GB, Wingard JR, Saral R, Griffin C, Shah N, Zehnbauer BA, Ambinder R, Burns W, Jones R, May WS, Rowley S, et al. Bone marrow transplantation of chronic myelogenous leukemia in chronic phaseevaluation of risks and benefits Journal of Clinical Oncology. 10: 779-789. PMID 1569450  1
1992 Griffin CA, Zehnbauer BA, Beschorner WE, Ambinder R, Mann R. t(11;18)(q21;q21) is a recurrent chromosome abnormality in small lymphocytic lymphoma Genes Chromosomes and Cancer. 4: 153-157. PMID 1373316 DOI: 10.1002/gcc.2870040209  1
1992 Mann RB, Wu TC, MacMahon EM, Ling Y, Charache P, Ambinder RF. In situ localization of Epstein-Barr virus in thymic carcinoma Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 5: 363-366. PMID 1323108  1
1992 Shah WA, Ambinder RF, Hayward GS, Hayward SD. Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions. Journal of Virology. 66: 3355-62. PMID 1316452  1
1992 Wu TC, Hruban RH, Ambinder RF, Pizzorno M, Cameron DE, Baumgartner WA, Reitz BA, Hayward GS, Hutchins GM. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts American Journal of Pathology. 140: 739-747. PMID 1312309  1
1991 Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. Journal of Virology. 65: 1466-78. PMID 1847464  1
1991 MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, McArthur JC, Ambinder RF. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 338: 969-73. PMID 1681341 DOI: 10.1016/0140-6736(91)91837-K  1
1991 Ambinder RF, Griffin CA. Biology of the lymphomas: Cytogenetics, molecular biology, and virology Current Opinion in Oncology. 3: 806-812. PMID 1661167  1
1991 Wu TC, Mann RB, Epstein JI, MacMahon E, Lee WA, Charache P, Hayward SD, Kurman RJ, Hayward GS, Ambinder RF. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. The American Journal of Pathology. 138: 1461-9. PMID 1647139  1
1990 Ambinder RF, Lambe BC, Mann RB, Hayward SD, Zehnbauer BA, Burns WS, Charache P. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Molecular and Cellular Probes. 4: 397-407. PMID 2177846 DOI: 10.1016/0890-8508(90)90030-4  1
1990 Ambinder RF. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1 Hematology/Oncology Clinics of North America. 4: 821-833. PMID 2172203  1
1990 Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. International Journal of Cancer. Journal International Du Cancer. 46: 801-4. PMID 2172169 DOI: 10.1002/ijc.2910460509  1
1990 Hruban RH, Wu TC, Beschorner WE, Cameron DE, Ambinder RF, Baumgartner WA, Reitz BA, Hutchins GM. Cytomegalovirus nucleic acids in allografted hearts Human Pathology. 21: 981-983. PMID 2168339 DOI: 10.1016/0046-8177(90)90186-9  1
1990 Ambinder RF, Shah WA, Rawlins DR, Hayward GS, Hayward SD. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. Journal of Virology. 64: 2369-79. PMID 2157891  1
1990 Ambinder RF. Recent experimental studies in lymphoma: Molecular and virologic aspects Current Opinion in Oncology. 2: 811-815. PMID 1965693  1
1989 Staal SP, Ambinder R, Beschorner WE, Hayward GS, Mann R. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease American Journal of Clinical Pathology. 91: 1-5. PMID 2535912  1
1988 Schachat AP, Jabs DA, Graham ML, Ambinder RF, Green WR, Saral R. Leukemic iris infiltration Journal of Pediatric Ophthalmology and Strabismus. 25: 135-138. PMID 3165128  1
1987 Santos GW, Saral R, Burns WH, Braine HG, Sensenbrenner LL, Wingard JR, Yeager AM, Jones R, Ambinder RF, Rowley SD, May S, Vogelsang GB. Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas — Baltimore experiences Acta Haematologica. 78: 175-180. PMID 3124443 DOI: 10.1159/000205926  1
1987 Ambinder RF, Newman C, Hayward GS, Biggar R, Melbye M, Kestens L, Van Marck E, Plot P, Gigase P, Wright PB, Quinn TC. Lack of Association of Cytomegalovirus with Endemic African Kaposi’s Sarcoma Journal of Infectious Diseases. 156: 193-197. PMID 3036956 DOI: 10.1093/infdis/156.1.193  1
1987 Pepose JS, Newman C, Bach MC, Quinn TC, Ambinder RF, Holland GN, Hodstrom PS, Frey HM, Foos RY. Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir Ophthalmology. 94: 414-424. PMID 3035452  1
1986 Epstein JI, Ambinder RF, Kuhajda FP, Pearlman SH, Reuter VE, Mann RB. Localized herpes simplex lymphadenitis American Journal of Clinical Pathology. 86: 444-448. PMID 3766459  1
1986 Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide New England Journal of Medicine. 315: 141-147. PMID 3523241  1
1986 Ambinder RF, Charache P, Staal S, Wright P, Forman M, Hayward SD, Hayward GS. The vector homology problem in diagnostic nucleic acid hybridization of clinical specimens. Journal of Clinical Microbiology. 24: 16-20. PMID 3013928  1
1986 Ambinder RF, Burns W, Forman M, Charache P, Arthur R, Beschorner W, Santos G, Saral R. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation Archives of Internal Medicine. 146: 1400-1401. PMID 3013110 DOI: 10.1001/archinte.146.7.1400  1
1985 Ambinder RF, Wingard JR, Burns WH, Hayward SD, Saral R, Perry HR, Santos GW, Hayward GS. Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. Journal of Clinical Microbiology. 21: 353-6. PMID 2984244  1
1984 Ambinder R, Burns W, Lietman P, Saral R. Prophylactic acyclovir therapy and herpes simplex Annals of Internal Medicine. 100: 920-921. PMID 6721313  1
1984 Hayward GS, Ambinder R, Ciufo D, Hayward SD, LaFemina RL. Structural organization of human herpesvirus DNA molecules. The Journal of Investigative Dermatology. 83: 29s-41s. PMID 6330219  1
1984 Smith CR, Ambinder R, Lipsky JJ, Petty BG, Israel E, Levitt R, Mellits ED, Rocco L, Longstreth J, Lietman PS. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial Annals of Internal Medicine. 101: 469-477. PMID 6089633  1
1983 Saral R, Ambinder RF, Burns WH, Angelopulos CM, Griffin DE, Burke PJ, Lietman PS. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study Annals of Internal Medicine. 99: 773-776. PMID 6359995  1
1983 Balfour HH, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, Zaia JA, Aeppli D, Kirk LE, Segreti AC, Keeney RE. Acyclovir halts progression of herpes zoster in immunocompromised patients New England Journal of Medicine. 308: 1448-1453. PMID 6343861  1
1979 Ambinder RF, Schuster MM. Endorphins: New gut peptides with a familiar face Gastroenterology. 77: 1132-1140. PMID 226450  1
1979 Ambinder RF, Tucker H, Schuster MM. Possible role of endogenous opiate peptides (endorphins) in the pathogenesis of irritable bowel syndrome Gastroenterology. 76: 1304.  1
Show low-probability matches.